05:06 PM EDT, 10/10/2024 (MT Newswires) -- Sanofi ( SNY ) is nearing a deal to sell a majority stake in its Opella consumer health subsidiary to Clayton Dubilier & Rice for 15 billion euros ($16.4 billion), Bloomberg reported Thursday, citing people familiar with the matter.

A deal might be announced within a few days, and the French drug maker likely will retain a minority stake in Opella, the report said.

Sanofi ( SNY ) wasn't immediately available for comment, and Clayton Dubilier & Rice declined to comment, Bloomberg said.

Sanofi ( SNY ) and the private equity firm didn't immediately respond to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 55.00, Change: +0.23, Percent Change: +0.42